PerformanceMedium Risk
GHRP-6
Also known as: Growth Hormone Releasing Peptide-6
- Half-life:
- 15-60 minutes
Administration Routes
subcutaneous injectionintranasal
PeptideBase provides educational research tools and provider discovery. It does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing instructions. Consult a qualified healthcare professional before making health decisions.
Mechanism of Action
Ghrelin receptor agonist; stimulates pituitary GH release and increases appetite via hypothalamic ghrelin pathways
A hexapeptide that strongly stimulates growth hormone release while also increasing appetite. Commonly used for muscle gain and recovery.
Primary Research Areas
- GH release
- appetite stimulation
- muscle growth
- fat loss
Risk Profile
Medium Risk
Moderate risk profile in research contexts. Consult a healthcare professional before use.
Regulatory Status
Research OnlyNot Evaluated by FDA
Hexapeptide GH secretagogue. No FDA approval. Not on FDA Category 1 or Category 2 compounding list. WADA prohibited. Historical Phase 2 trials (Theratechnologies) but abandoned. Research chemical.
Regulatory status reflects publicly available information and may change. This is not legal or medical advice.